Pavise Serum

N/A

Report date: 2026/03/24 20:00:35

Base Information

Drug NamePavise Serum
Drug Alias NamePavise ECMR (extracellular matrix restore) serum
ClassificationBiologics > Blood componentsCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCutis Laxa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesB.A.I. Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesB.A.I. Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCutis Laxa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A